I-Sichuan Deebio Pharmaceutical Co., Ltd yamukele ukuhlolwa okusemthethweni kwe-GMP okuvela e-Japan PMDA kusukela ku-8.25 kuya ku-8.26 ngo-2022. Ithimba labacwaningi mabhuku be-GMP lakhiwe abacwaningi mabhuku ababili abaholwa ochwepheshe abangomakadebona futhi lenza ukuhlola okukude kwezinsuku ezimbili.Ochwepheshe bethimba lokuhlola benze ukuhlola okuphelele kwesistimu yokuphatha ikhwalithi ye-Deebio, uhlelo lokuphatha ukukhiqiza, ukusebenza endaweni, ukuphathwa kwelabhorethri, izinsiza ezihambisanayo ezisekelayo kanye nemishini, kanye nokugcinwa kwezinhlelo zomphakathi.

Ngokuhlola, ochwepheshe bethimba lokuhlola baye baqinisekisa ngazwi linye futhi baqaphela kakhulu uhlelo lokuphatha ikhwalithi ye-Deebio ye-GMP.Ekugcineni, u-Deebio uphumelele ngempumelelo isitifiketi se-GMP se-PMDA yaseJapan!

I-PMDA (I-Pharmaceuticals and Medical Devices Agency) iyisikhungo sase-Japan esibhekele ukubuyekezwa kobuchwepheshe kwezidakamizwa namadivayisi ezokwelapha.Isebenza ngokufana ne-FDA e-United States kanye ne-NMPA e-China.

U-Deebio uphumelele isitifiketi se-EU-GMP nesiShayina se-GMP.Ukuphasa ngempumelelo kwesitifiketi se-PMDA yase-Japan kuphawula ukunqoba kwezigaba ngesu lembulunga yonke lika-Deebio!